Dr. Jimmy Zhang has 20+ years of experience and expertise in both large pharmas and start-up companies, in strategy, management, business development, and operations, as well as in venture investments.  Jimmy is founder, chairman and CEO of AccuGen Group, focusing on gene and cell therapy.  He was a Venture Partner at Lilly Asia Ventures (LAV), and Vice President of Transactions at Johnson & Johnson, where he led the transactional and partnership management activities and strategy in Asia Pacific region in pharmaceuticals, medical devices & diagnostics and consumer products, as well as fund relationship and partnership.  Jimmy was the Managing Director, MSD Early Investments – Greater China at Merck & Co., and a member of Merck Research Lab (China) Senior Leadership Team.  He was also a Board Director of BeiGene (Beijing) Co, Ltd. and an Advisor Board member of Cenova Ventures.  Jimmy was previously SVP at Synergenics (an accelerator founded and led by Dr. Bill Rutter, one of the founding fathers and pioneers of the biotech industry), a consultant at McKinsey & Company, a registered patent agent in the Palo Alto office of Morrison & Foerster, and a project manager at Chiron Corporation (now part of Novartis). Jimmy was a founding member and former Chairman of BayHelix Group.  He is an adjunct professor and master degree mentor at Yeehong Business School at Shenyang Pharmaceutical University.  He holds an MBA from MIT Sloan School of Management, where he was elected as the treasurer of MIT Graduate Student Council; a PhD in biomedical sciences from University of Texas Southwestern Medical Center at Dallas, where he worked closely with three Nobel Laureates; and a BS in biochemistry from Nanjing University.  Jimmy published in Cell, Nature, Neuron, and JBC, and holds multiple patents.